Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed with Medincell, for adults living with bipolar I disorder. This move ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks under $100. On October 9, BofA raised the firm’s price target on Teva to $24 from $22, while keeping a Buy rating ...

(RTTNews) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), in collaboration with Medincell (MEDCL.PA), announced that the U.S. Food and Drug Administration has ...

Teva Pharmaceutical Industries Limited is regaining investor interest as restructuring efforts drive margin improvements and unlock pipeline potential. Turnaround: company is changing to a more ...

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs. White House spokesman Kush Desai told the Wall Street Journal that "the administration is not actively ...

PARSIPPANY, N.J. - The U.S. Food and Drug Administration has approved UZEDY (risperidone) extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults, Teva ...

Over the past year, Druckenmiller's family office fund has jettisoned its stake in Nvidia and Palantir. While Druckenmiller is clearly bullish on artificial intelligence, he is also wary of high ...

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International ...

HARTLEY, Iowa (KTIV) - Parents in Hartley, Iowa demanding action, for an issue they say puts young children at risk. “I want people to know that, you know, they’re not alone in their fear of this ...